Overall, our present study demonstrated that ROS induces GCLC desuccinylation and consequent activation through enhancing its interaction with desuccinylase SIRT2, which represents an essential mechanism for cancer cells to evade oxidative stress-induced ferroptosis, and constitutes a potential target for clinical cancer treatment. The gene discussed is GCLC; the disease is cancer.